ARMP
Armata Pharmaceuticals
$5.15
+$0.49 (+10.52%)Jul 27, 2026
Key metrics
The numbers that frame ARMP today
- Market cap
- $189.06M
- P/E (TTM)
- -0.7
- EV / FCF
- -22.6
- ROIC
- -110.6%
- Div yield
- 0%
- 52wk Low
- $2.35
- 52wk High
- $16.34
Growth
Revenue and earnings trend for ARMP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARMP
Is Armata Pharmaceuticals a good buy?
Hold. Armata Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Armata Pharmaceuticals is selling at a very high price.
What is the market capitalization of ARMP?
Armata Pharmaceuticals's market capitalization is $189.06M.
What is the P/E ratio for ARMP stock?
Armata Pharmaceuticals's current P/E ratio is -0.7.
What is the 52-week high for ARMP stock?
The 52-week high for Armata Pharmaceuticals is $16.34. The current close of $5.15 is 68.5% below that high.
What is the 52-week low for ARMP stock?
The 52-week low for Armata Pharmaceuticals is $2.35. The current close of $5.15 is 119.1% above that low.
Does ARMP stock pay dividends?
Armata Pharmaceuticals does not currently show a dividend per share in the company data.